This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,870.55, is for the delivery of Famotidine 40 mg/5 ml suspension, a medication used to treat gastrointestinal conditions. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 6, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award does not indicate the use of any set-aside designations, suggesting open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems.
Generated 2/4/25, 10:40 AM